
Telemedicine companies at the Series A to Series C stage face a specific problem: you need senior growth and marketing leadership who understands healthcare regulations, physician adoption, and patient acquisition – but a $300K+ CMO hire does not make sense until you have product-market fit dialed in. Fractional leadership fills that gap.
Junior marketing teams make expensive mistakes in regulated healthcare
Telemedicine marketing has real consequences when done wrong. Non-compliant advertising can trigger regulatory action. Physician outreach that feels like spam burns bridges you cannot rebuild. Patient acquisition campaigns that promise outcomes you cannot deliver create legal exposure. Without experienced leadership, marketing teams in telemedicine move slowly out of fear or fast into compliance violations.
Healthcare marketing leadership is scarce and expensive
The pool of marketing executives who understand both growth-stage operations and healthcare regulations is extremely small. A full-time CMO with telehealth experience commands $250K-400K in total compensation plus equity. For a Series A company with $5M-15M ARR, that is a significant portion of the operating budget committed to a single role before you know what growth motions actually work.
Board and investor expectations require senior-level strategy
Investors expect coherent growth narratives and measurable marketing plans. They want to see CAC by channel, LTV by segment, and a clear path to efficient scale. Your board deck needs the kind of strategic framing that comes from executive experience, not from a marketing manager running campaigns. Without that senior perspective, fundraising conversations stall and board confidence erodes.
Physician and health system channels require executive relationships
Health system partnerships, physician network deals, and payer relationships are executive-level conversations. Marketing directors do not get meetings with Chief Medical Officers or VP of Digital Health at major health systems. You need someone with the title, the network, and the credibility to open those doors and translate your value proposition in clinical terms.
Our fractional CXO model places experienced healthcare marketing and growth executives inside your telemedicine company on a part-time basis. These are operators who have built and scaled healthcare brands, navigated FDA and HIPAA marketing requirements, and developed physician adoption strategies at other virtual care companies. They work as members of your leadership team, not as outside consultants.
The engagement starts with a strategic assessment. Your fractional CXO audits current marketing operations, evaluates team capabilities, reviews regulatory compliance posture, and maps stakeholder relationships. Within the first 30 days, you get a clear picture of what is working, what is not, and what needs to change to hit your growth targets.
From there, your fractional leader builds the growth plan. This includes channel strategy for physician acquisition and patient growth, messaging frameworks that pass regulatory review, team hiring and development plans, and measurement systems that connect marketing spend to clinical and business outcomes. They run weekly leadership meetings, join board presentations, and manage vendor relationships.
What makes this different from a consulting engagement is continuity. Your fractional CXO is embedded in your company for months, not weeks. They build relationships with your clinical team, your sales organization, and your board. They make hiring decisions, set budgets, and own results. The goal is building a marketing function that works, then handing it off to a full-time hire when the company is ready.
The most expensive marketing mistake telemedicine companies make is not hiring too late – it is hiring the wrong level of leadership too early. A fractional CXO gives you the strategic direction first, so when you do hire full-time, you know exactly what role you need.
The first 30 days are diagnostic. Your fractional CXO meets with every stakeholder who touches marketing and growth – clinical leadership, sales, product, customer success, and the board. They audit existing campaigns, review regulatory compliance, assess team capabilities, and benchmark against competitors. By day 30, you have a clear strategic assessment and a prioritized action plan.
Days 31-60 shift to execution. Your fractional leader implements the highest-impact changes identified in the assessment. This typically includes messaging overhauls, channel optimization, team restructuring, and establishing measurement frameworks. They start building the processes and playbooks that will outlast their engagement.
Days 61-90 focus on scaling and transition planning. With foundational improvements in place, the focus shifts to building repeatable systems, documenting strategies, and preparing for either continued fractional support or a full-time leadership hire. Your fractional CXO creates detailed hiring profiles, interview guides, and onboarding plans so the transition to permanent leadership is smooth.
Fractional CXO engagements typically start at 2-3 days per week, adjusting based on company stage and marketing complexity. Your fractional leader attends leadership meetings, manages the marketing team, and is available for ad hoc strategic decisions throughout the week. They are not a consultant who shows up for a weekly call – they are an embedded member of your executive team.
Engagements typically run 6-12 months. Some companies extend to 18 months through major fundraising rounds or market expansions. The goal is always to build toward a full-time hire when the company's scale justifies it. Your fractional CXO often helps recruit, interview, and onboard their permanent replacement.
From your side, the fractional leader needs direct access to the CEO, board materials, financial data, and the clinical team. They also need decision-making authority within agreed-upon boundaries. The arrangement works best when the fractional CXO is treated as a real member of the leadership team, not as an outside advisor.
If your telemedicine company needs fractional cxo leadership, we should talk.

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Fractional CXO engagements typically run $15K-30K per month depending on time commitment and company complexity. At 2-3 days per week, this represents a fraction of the $250K-400K total compensation a full-time healthcare CMO commands. Most telemedicine companies engage for 6-12 months, giving them senior leadership during the critical growth phase when strategic direction matters most.
A consultant gives you a strategy deck and leaves. A fractional CXO stays, implements, manages your team, attends board meetings, and owns outcomes. They have decision-making authority, manage budgets, and are accountable for growth metrics. The difference is ownership. Consultants advise. Fractional executives operate.
Our fractional leaders have direct experience with healthcare marketing regulations including HIPAA, FTC health claims guidelines, and state telemedicine laws. They know what you can and cannot say in patient acquisition campaigns, physician recruitment materials, and investor presentations. Regulatory fluency is a prerequisite for anyone we place in a telemedicine company, not a nice-to-have.
They manage your team directly. This includes setting priorities, running weekly meetings, providing coaching, and making hiring recommendations. For early-stage companies with one or two marketers, the fractional CXO provides the strategic direction that lets junior team members execute effectively. For larger teams, they bring organizational structure and accountability that accelerates output.
Generally when you have clear product-market fit, repeatable growth channels, and enough marketing budget to justify a $250K+ hire. For most telemedicine companies, that is somewhere around $20M-40M ARR. Before that point, a fractional CXO gives you the strategic leadership you need while preserving cash and maintaining flexibility. Your fractional leader can help you determine exactly when the transition makes sense.
Most fractional leaders deliver a strategic assessment with actionable recommendations within the first 30 days. Quick wins in messaging, channel optimization, and team alignment often appear within 6-8 weeks. Structural improvements to growth operations, board reporting, and stakeholder relationships develop over 3-6 months. The speed depends partly on how much access and authority you give them from day one.
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, June 9, 2026
Frank Growth – Episode 223 – Most Tests Will Fail, That’s Fine with Divya Ramaswamy
Tuesday, June 2, 2026
Frank Growth – Episode 222 – Getting a CFO on Board with Your Growth Plan with Simon Heyrick
Tuesday, May 5, 2026
Frank Growth – Episode 218 – The Sephora of Chocolate Strategy with Pashmina De Shon
Ready to unlock your growth?
Book Free Call